Patricia Thomson, a married, working mother whose leukemia is in remission, is one of the many cancer patients struggling to pay for her medication. One of her prescriptions, Sprycel, is helping to keep her alive but it costs at least $106,000 a year. Even with Medicare payments, Thomson ...
Dasatinib Sprycel 0003-0524 (E.R.) 6/28/06 Treatment of CML in chronic, accelerated, or blast-phase resistant or intolerant to previous therapy (including imatinib), treatment of newly diagnosed Philadelphia chromosome–positive CML in chronic phase, Ph+ ALL resistant or intolerant to previous th...